Monday, December 23, 2024
HomeTagsDavid R. Gandara

David R. Gandara

Libtayo in Combination with Chemotherapy Approved by the FDA as First-line Treatment

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) in combination with platinum-based chemotherapy...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics